ARCT
Arcturus Therapeutics Holdings Inc
13.90$
-1.9%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -74.7% | -2.5% | -17.0% | -65.6% | -61.2% | -1.4% | -119.6% | -23.5% | -100.0% | -526.7% | -3,187.0% | -672.9% | -305.6% | |
| 1.9% | 3.2% | 2.8% | 2.0% | 2.3% | 3.9% | 2.7% | 3.2% | 4.4% | 22.1% | 107.9% | 21.7% | 11.5% | |
| 21.4% | 35.2% | 30.9% | 20.5% | 24.5% | 42.8% | 22.7% | 25.3% | 33.4% | 221.3% | 709.0% | 143.0% | 88.7% | |
| -92.5% | 5.8% | 31.3% | -51.4% | -70.8% | 95.7% | -97.2% | -15.0% | -60.4% | 96.1% | 421.8% | -35.8% | -24.8% | |
| 2.3% | 3.5% | 0.7% | 0.7% | 0.2% | 0.0% | 0.5% | 0.0% | 1.1% | 4.5% | 0.0% | 0.0% | 1.3% | |
| -2.3% | -3.5% | -0.7% | -0.7% | -0.2% | 0.0% | -0.5% | 0.0% | -1.1% | 2.8% | 5.6% | 0.6% | -0.2% | |
| – | – | – | – | 0.0% | 0.0% | 51.1% | -61.2% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | |
| 50.4% | -74.4% | 6.7% | 5.2% | 1.8% | 0.6% | 51.7% | -60.1% | 7.1% | 379.4% | 2.6% | 0.5% | 54.4% | |
| -26.6% | -80.4% | -11.1% | -61.0% | -59.6% | -0.7% | -68.3% | -83.6% | -93.9% | -144.5% | -3,178.9% | -672.3% | -251.4% | |
| -77.0% | -6.0% | -17.8% | -66.3% | -61.4% | -1.4% | -120.1% | -23.5% | -101.1% | -531.1% | -3,187.0% | -672.9% | -306.9% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.